Page last updated: 2024-08-25

2-bromopalmitate and Diabetes Mellitus

2-bromopalmitate has been researched along with Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ailhaud, G; Amri, EZ; Cawthorne, MA; Gaillard, D; Grimaldi, PA; Ibrahimi, A; Teboul, L; Young, P1
Chauvet, MC; Henly, DC; Phillips, JW1

Other Studies

2 other study(ies) available for 2-bromopalmitate and Diabetes Mellitus

ArticleYear
Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
    Molecular pharmacology, 1994, Volume: 46, Issue:6

    Topics: 3T3 Cells; Adipose Tissue; Animals; Carrier Proteins; Cells, Cultured; Diabetes Mellitus; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Gene Expression Regulation; Hypoglycemic Agents; Kinetics; Mice; Neoplasm Proteins; Nerve Tissue Proteins; Palmitates; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones

1994
Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats.
    Diabetes, 1999, Volume: 48, Issue:2

    Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids; Glucose; Hyperglycemia; Liver; Obesity; Oxidation-Reduction; Palmitates; Rats; Rats, Zucker; Reference Values

1999